Who owns Ernexa Therapeutics Inc?
- Ticker: ERNA
- CUSIP Number: 114082308
Tip: Access positions for across all investors
Analyze quarterly positions in Ernexa Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ernexa Therapeutics stock
Who bought or sold Ernexa Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| CI Private Wealth | 438k | $87k | 0% | Mar 2026 |
|
| Geode Capital Management | 244k | $49k | 935% | Mar 2026 |
|
| Warberg Asset Management | 50k | $10k | 100% | Mar 2026 |
|
| Jane Street | 41k | $8.2k | 100% | Mar 2026 |
|
| Vanguard Group | 36k | $43k | 222% | Dec 2025 |
|
| Citadel Advisors | 33k | $6.6k | 100% | Mar 2026 |
|
| Vanguard Capital Management | 27k | $5.3k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 25k | $5.1k | 100% | Mar 2026 |
|
| UBS Group | 21k | $4.2k | 3439% | Mar 2026 |
|
| Goldman Sachs Group | 17k | $3.3k | 100% | Mar 2026 |
|
| Sippican Capital Adivsors | 10k | $2.0k | 0% | Mar 2026 |
|
| BlackRock | 820.00 | $163.016000 | 0% | Mar 2026 |
|
| Assetmark | 133.00 | $26.001500 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 10.00 | $2.000000 | 0% | Mar 2026 |
|
| A. Montag and Associates | 8.00 | $2.000000 | 0% | Mar 2026 |
|
| SBI Securities | 6.00 | $1.000200 | 100% | Mar 2026 |
|
| Activest Wealth Management | 3.00 | $0.999900 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 1.00 | $0 | 100% | Mar 2026 |
|
Who sold out of Ernexa Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2025 | 31k | $34k |
| Hrt Financial | Dec 2025 | 13k | $15k |
| Tower Research Capital | Sep 2025 | 5.2k | $5.7k |
| Fortitude Family Office | Dec 2025 | 804.00 | $964.960800 |